IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy
about
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cellsTrial Watch: Adoptive cell transfer for oncological indicationsGenetically modified T cells for the treatment of malignant diseaseInterleukin 12: still a promising candidate for tumor immunotherapy?A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model.Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor modelMolecular imaging of cell-based cancer immunotherapy.Effects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapyImmune cells: more than simple carriers for systemic delivery of oncolytic viruses.Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumoniaTrial Watch: Adoptive cell transfer immunotherapy.Cytokine-induced killer cells promote antitumor immunityTrial Watch: Adoptive cell transfer for anticancer immunotherapy.Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion.Gene expression profiling of breast cancer in Lebanese women.Innate immune cells in breast cancer--from villains to heroes?New adoptive immunotherapy strategies for solid tumours with CIK cells.An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells.A killer choice for cancer immunotherapy.IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killingCytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.Enhancement of the cytotoxic activity of cytokine-induced killer cells transfected with IL3PE38KDEL gene against acute myeloid leukemia cells.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity.
P2860
Q26766184-29C8578A-15DD-411B-AB19-86C9E81A6BCDQ26785545-C77426D3-9DDB-4A75-A408-1C747DBB2CCEQ26860657-A59B8A4C-F381-4BBB-BEC8-3281BD5D390AQ26861559-6226D471-823A-489A-BBE9-D7ADCB5A50A6Q34147593-328BC4E2-67C3-45FF-8249-4344B76F6B39Q34427459-BEA92A23-0D4F-442C-BEF3-EB7623537104Q34717870-E78C620C-6822-4F19-8532-A9C72E7F5BF8Q34918975-FD1A1F4D-047A-478F-A704-B9E0F94181FFQ35162284-5970F47E-EB74-41AB-ABD2-E7E3ADBFDDE5Q36010779-0399C21C-2106-4267-B085-9B500A164857Q36057432-35349E59-C78C-476F-9B7E-2D201F036C55Q36741617-FA7AB5BD-D425-4939-9632-98D221DDE839Q36887833-923BA3A9-7C94-4627-B820-A69E5DE320CBQ37395436-20C41DBF-6485-4633-9C4B-C03E3C37DDCAQ37421684-FFD86245-FF01-463D-B6DA-CAA463EE1529Q37905673-B6E38B5C-EF56-4798-BC88-CAC5294268E5Q37996561-F00A85CF-6F1F-4266-A95A-09E89CCD5C73Q38199717-6DA5B285-F2A3-4144-9155-7A0D73059D94Q38208944-D9B35E89-B9D3-4E69-BA39-CBF054D54CCEQ40987686-FCDE461E-FEFD-4532-B839-D487FB350173Q42174988-6D4DED72-7F4A-4E32-8C94-B6BACC205EA9Q42175389-49159BBD-68E6-4D09-A4E9-F75398030FAEQ42462202-CD6F52B9-93AF-43E3-B1A0-ABDF766617B1Q42702234-9428BFC1-4C4D-44B2-9106-6416604EAD54Q52649735-3691623C-B792-4A4F-ADCD-DCB86A288C73
P2860
IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-12 enhances efficacy and sh ...... uced killer cell immunotherapy
@en
IL-12 enhances efficacy and sh ...... ced killer cell immunotherapy.
@nl
type
label
IL-12 enhances efficacy and sh ...... uced killer cell immunotherapy
@en
IL-12 enhances efficacy and sh ...... ced killer cell immunotherapy.
@nl
prefLabel
IL-12 enhances efficacy and sh ...... uced killer cell immunotherapy
@en
IL-12 enhances efficacy and sh ...... ced killer cell immunotherapy.
@nl
P2093
P2860
P1476
IL-12 enhances efficacy and sh ...... uced killer cell immunotherapy
@en
P2093
Mike W Helms
Steven Schaffert
P2860
P2888
P304
P356
10.1007/S00262-010-0860-Y
P577
2010-06-09T00:00:00Z